This patent is useful for generation of skin cells and skin-like cells from umbilical cords. Since cord blood is extracted from the cord and the cord is usually disposed of, this patent may be of particular importance. The only disadvantage of this patent is that its 1 issued claim seems to cover only a certain method of culturing the cells in a specific media.
A method of culturing umbilical cord epithelium cells, characterized by culturing in a medium umbilical cord epithelium cells separated from cells originated from tissue included in an umbilical cord, wherein the medium is a mixture of MCDB153 medium and DMEM medium in a volume ratio of 4:1 supplemented with epidermal growth factor, insulin, transferrin, hydrocortisone, ethanol amine, phosphoethanolamine and hypophysis extract.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.